Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.
Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.
复制标题
双(麦芽糖)氧钒对实验性血管内皮功能障碍的影响。
DOI:
10.1007/s00210-006-0066-1
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
Singh,Manjeet
中科院分区:
文献类型:
--
作者:
Shah,DhvanitI;Singh,Manjeet
The study has been designed to investigate the effect of bis(maltolato) oxovanadium (BMOV), a protein tyrosine phosphatase inhibitor, on hypercholesterolemia and hypertension-induced vascular endothelial dysfunction. High fat diet (8 weeks) and deoxycorticosterone acetate (DOCA; 40 mg kg−1, s.c.) were administered to rats to produce hypercholesterolemia and hypertension (mean arterial blood pressure >120 mmHg) respectively. Vascular endothelial dysfunction was assessed using isolated aortic ring preparation, electron microscopy of thoracic aorta, and serum concentration of nitrite/nitrate. Serum thiobarbituric acid reactive substances (TBARS) were estimated to assess oxidative stress. BMOV (0.2 mg/ml in drinking water) or atorvastatin (30 mg kg−1, p.o.) markedly improved acetylcholine-evoked endothelium-dependent relaxation, lining of vascular endothelium, serum nitrite/nitrate concentration, and serum TBARS in hypercholesterolemic and hypertensive rats. However, this ameliorative effect of BMOV has been prevented by L-NAME (25 mg kg−1, i.p.), an inhibitor of NOS, or by glibenclamide (5 mg kg−1, i.p.), a blocker of ATP-sensitive K+channels. It may be concluded that BMOV-induced inhibition of PTPase may improve vascular endothelial dysfunction.